Currently out of the existing stock ratings of Constantine Davides, 38 are a BUY (100%).

Constantine Davides

Work Performance Price Targets & Ratings Chart

Analyst Constantine Davides works at JMP with a stock forecast success ratio of 20% fulfilled within 32.33 days on average. Previously, Constantine Davides worked at BENCHMARK.

Constantine Davides’s has documented 74 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AMN, AMN Healthcare Services at 10-May-2024.

Wall Street Analyst Constantine Davides

Analyst best performing recommendations are on ISPC (ISPECIMEN).
The best stock recommendation documented was for ISPC (ISPECIMEN) at 11/23/2021. The price target of $12 was fulfilled within 1 day with a profit of $1.19 (9.02%) receiving and performance score of 90.22.

Average potential price target upside

ACER Acer Therapeutics BIVI Biovie ACST Acasti Pharma ELMD Electromed HCTI Healthcare Triangle HCWB HCW Biologics HOTH Hoth Therapeutics INVA Innoviva ISPC iSpecimen KTTA Pasithea Therapeutics Corp LGVN Longeveron LLC NMRD Nemaura Medical NNVC NanoViricides MEDS Trxade Group AGL agilon health AMN AMN Healthcare Services

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1.5

$0.84 (127.27%)

10

8 months 17 days ago

0/3 (0%)

$0.36 (31.58%)

Buy

8

$7.34 (1112.12%)

9

2 years 2 months 11 days ago

0/2 (0%)

$5.54 (225.20%)

Buy

8

$7.34 (1112.12%)

48

4 years 10 months 23 days ago

0/4 (0%)

$3.88 (94.17%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Constantine Davides is most bullish on?

Potential upside of $16.32 has been obtained for AMN (AMN HEALTHCARE SERVICES)

Which stock is Constantine Davides is most reserved on?

Potential downside of $5.59 has been obtained for AGL (AGILON HEALTH)

What Year was the first public recommendation made by Constantine Davides?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?